While recent CDC guidance threatens to shrink the market for a new class of immunizations, GSK continues to build the case ...

U.S. sales of RSV vaccines from GSK and Pfizer are down significantly after regulators narrowed the targeted age group and ...

GSK said on Tuesday that its Arexvy respiratory syncytial virus vaccine was 43.3% effective in preventing severe illness in ...

Mumbai: A retired GlaxoSmithKline (GSK) employee, Ashok Shetty, on Monday reported a home burglary involving the theft of ...

Millions of people who bought DNA tests from genetic testing service 23andme have been urged to delete their personal data ...

DNA analysis company 23andme has been in trouble lately: data was breached in a 2023 hack, and this September the entire ...

ViiV Healthcare to triple annual supply of long-acting HIV PrEP for low- and middle-income countries ...

Barclays analyst Emily Field maintained a Hold rating on GlaxoSmithKline (GSK – Research Report) today and set a price target of £15.50.

The life sciences developer acquired the site as part of a master lease agreement with seller MIT that expires in 2099.

EU regulators are considering withdrawing market authorizations for two hair loss and enlarged prostate treatments over ...

"I've watched and been a part of Illumina growing from a startup to one of the most important and innovative companies in the ...

DNA submitted by users to the genealogy company 23andMe will remain private for now, with CEO Anne Wojcicki saying she no ...